ON DEMAND

The ABCs of CAB: Incorporating Long-acting CABENUVA into Clinical Practice

Cabotegravir/Rilpivirine: Congress Data

Cabenuva Post CROI 2022 Discussion

Cabenuva Post CROI 2022 Discussion

Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare

Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare

Mark Lewandowski, PharmD —Medical Director, ViiV Healthcare

Cabenuva Post CROI 2022 Discussion

Andrew Zolopa, MD—Head North American Medical Affairs, ViiV Healthcare

Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir, ViiV Healthcare

Mark Lewandowski, PharmD —Medical Director, ViiV Healthcare

X
ATLAS 2M Week 152 Data

ATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice

Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir

Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, Cabotegravir

ATLAS 2M Week 152 Data - Discussion and Application to Clinical Practice

Paula Teichner, PharmD—Regional Medical Lead, Cabotegravir

Jean Van Wyk, MBChB; MFPM—VP and Global Medical Lead, Cabotegravir

X
Post-CROI 2021 Webinar

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs

Post-CROI 2021 Webinar

Andrew Zolopa, MD, VP, Head, North America Medical Affairs

X

Are you a US healthcare provider?

This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.

Connect with our Medical Experts

Find my ViiV MSL

Easily find the ViiV Medical Science Liaison (MSL) in your area.

Request a Scientific Discussion

Submit a request for additional information from a ViiV Medical Expert.

Talk to a Medical Expert

Connect now with a live ViiV Medical Expert.

Contact Us

Chat Live

Get immediate assistance from a ViiV Healthcare Professional.

Call 1-888-226-8434

Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1-877-844-8872 or FDA at 1-800-332-1088 or www.fda.gov/medwatch